Lei Deng

14PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 10, 2026
Comparing the Prognosis of Non-Small Cell Lung Cancer Patients Who Did Not Undergo Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy: A Retrospective Study.

Zhenghui Ma, Yuqi Wu, Guangqian Ji

|Oct 15, 2025
Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial.

Weiming Han, Linrui Gao, Xiaomin Wang

|Mar 29, 2025
Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma.

Canjun Li, Xin Wang, Lei Deng

|Mar 01, 2024
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol.

Lei Deng, Gulidanna Shayan, Wei Jiang

|Aug 19, 2023
Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trial.

Zeliang Ma, Bin Liang, Ran Wei

|May 28, 2022
Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score-matched analysis.

Chanjuan Cui, Xi Wu, Lei Deng

Pageof 3

Frequent Collaborators

5 joint publications

Zhouguang Hui

3 joint publications

Jie Wang

3 joint publications

Meng Yuan

3 joint publications

Zongmei Zhou